Navigation Links
Photodynamic therapy effective for certain head and neck cancers
Date:10/4/2009

San Diego, CA A combination of medications and a particular light therapy is effective at treating certain types of head and neck cancers in subtropical climates.

In a paper presented at the 2009 American Academy of Otolaryngology Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO in San Diego, researchers from the University of Miami presented findings from a study on dysplasia and carcinomas of the head and neck. It analyzed the effect of photodynamic therapy (PDT), a treatment that uses a drug, called a photosensitizer or photosensitizing agent, and a particular type of light in tropical climates. The study involved 24 males and 22 females, with an average age of 66 years. A total of 82 different lesions were treated, mostly in the oral cavity and vocal chords.

Results revealed that organ preservation and cancer cure can be achieved in patients with recurrent cancer that is superficially spread in the head and neck, but not deeply infiltrated. However, the authors cautioned that patients need extensive instruction on how to take the medications and follow-up counseling.

PDT is usually performed as an outpatient procedure, may be repeated, and may be used with other therapies, such as surgery, radiation, or chemotherapy, giving patients a variety of treatment options.


'/>"/>

Contact: Jessica Mikulski
newsroom@entnet.org
703-535-3762
American Academy of Otolaryngology -- Head and Neck Surgery
Source:Eurekalert

Page: 1

Related medicine news :

1. Combined stenting and photodynamic therapy improves survival in late stage liver cancer patients
2. IlluminOss Announces First Human Case Utilizing Its Innovative Photodynamic Bone Stabilization System Technology
3. IlluminOss(TM) Photodynamic Bone Stabilization System Receives CE Mark
4. Vision restoration therapy shown to improve brain activity in brain injured patients
5. HIV therapy in pregnancy-data support WHO recommendations
6. Family-based treatment more effective than supportive psychotherapy in treating bulimia
7. Trial to Test Gene Therapy for Angina in Women
8. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
9. Aromatherapy Gift Line Sheds Humorous Light on Modern Therapy
10. Chemotherapy may be culprit for fatigue in breast cancer survivors
11. Atlanta Falcons Physical Therapy Centers Set to Launch This Fall
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 2016 , ... David J. Dykeman , Ginger Pigott , and ... speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. ... firm’s global Life Sciences & Medical Technology Group have been featured speakers at every ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims ... employees that are both engaging and easy to use. Coming off the heels ... company revealed today its plans to roll out new AI-powered self-service enhancements to ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it had joined the ... as a non-profit organization to unite pharmaceutical and healthcare companies that share a ...
(Date:12/8/2016)... Dallas, TX (PRWEB) , ... December 08, 2016 , ... ... to continue to be a convenient service for Texas, they are expanding their presence ... will involve a hiring spree that will bring new jobs to the Dallas and ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are ... this in mind, SIGVARIS has created a new line of anti-embolism stockings to ... and provide the benefits of graduated compression when transitioning from recovery to early ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
(Date:12/8/2016)... Mass. , Dec. 8, 2016  EIP ... it has obtained proof-of-mechanism for neflamapimod (previously code ... completed Phase 2a clinical trials that demonstrated significant ... Study 302 (12-week treatment) and Study 303 (6-week ... Clinical Trials in Alzheimer,s Disease (CTAD) scientific conference ...
(Date:12/8/2016)... , Dec. 8, 2016 A Small ... the National Institutes of Health (NIH) to ... University.  The grant will seek to ... head device, which utilizes electromagnetic waves to treat Alzheimer,s ... this novel technology to possibly treat other neurologic disorders ...
Breaking Medicine Technology: